15 results on '"Karim Sultan Haider"'
Search Results
2. Change of categories of the International Prostate Symptom Score (IPSS) in hypogonadal patients with and without testosterone therapy for up to 14 years: Real-world data from two pooled controlled registry studies
3. Abstract #1216 Improvement of Blood Pressure (Bp); Heart Rate and Other Hemodynamic Markers in Hypogonadal Patients with Hypertension Receiving Long-Term Testosterone Therapy (Tth) Compared to Untreated Hypogonadal Controls: Real-Life Data from a 10-Year Registry
4. Abstract #409 Hypogonadal Patient Suffers Two Major Cardiovascular Events Before Deciding to Commence Testosterone Treatment Under Which All His Risk Factors Improve
5. Urinary function improves in hypogonadal men receiving long-term treatment with testosterone compared to a hypogonadal control group: 6471 Patient-years of clinical experience
6. Long-term treatment with testosterone undecanoate injections (TU) results in sustained weigh loss in hypogonadal men: Real-world 14-years data from a controlled registry study
7. Abstract #214 Improvement of Glycemic Control and Insulin Resistance in Hypogonadal Men with Type 2 Diabetes (T2DM) Receiving Up to 10Years of Testosterone Treatment in A Real-Life Registry
8. Abstract #601 Mortality; Major Adverse Cardiovascular Events (Mace) and Weight are Reduced in 400 Hypogonadal Men on Long-Term Testosterone Therapy (TTH) Compared to 376 Untreated Hypogonadal Controls: Real-Life Data from A 10-Year Registry
9. Urinary function improves in hypogonadal men with moderate International Prostate Symptom Score (IPSS) treated for up to 10 years with testosterone in comparison to untreated controls
10. Abstract #1013: Incidence and Severity of Prostate Cancer are Lower in Hypogonadal Men Treated with Testosterone Compared to Untreated Hypogonadal and Eugonadal Men: Experience from a Single Urologist’s Office
11. Abstract #1017: Effects of Long-Term Testosterone Undecanoate (TU) Therapy in Hypogonadal Men with Osteoporosis: Reallife Data from a Registry Study
12. Testosterone therapy (TTh) improves urinary function and reduces major adverse cardiovascular events (MACE) in hypogonadal men with type 2 diabetes (T2DM) treated up to 8 years in comparison to an untreated control group
13. Abstract #512: Is Long-Term Testosterone Therapy Effective in Secondary Prevention of Major Adverse Cardiovascular Events (MACE) in Hypogonadal Men with a History of Cardiovascular Disease (CVD)? Real-Life Data from a Registry Study
14. Abstract #275: Effects of Long-Term Testosterone Undecanoate (TU) Therapy on Anthropometric Parameters in Hypogonadal Men with Type 2 Diabetes (T2DM): Real-Life Data from a Registry Study
15. 1005 Long-term effects on urinary function in hypogonadal men treated with testosterone undecanoate injections (TU) vs untreated controls from a single urologist's office: Real-life data from a registry study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.